NR4A1 and breast cancer: Apart from surgical excision and radiotherapy, systematic chemotherapy in adjuvant setting has been proved to bring about noticeable benefit in OS and DFS of elderly breast cancer women, particularly in hormone receptor (HR)-negative cohorts.